Marshall Wace
NMRD

Marshall Wace’s Nemaura Medical, Inc. Common Stock NMRD Stock Holding History

Marshall Wace’s Portfolio NMRD Stock Details NMRD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-62,807
Closed -$650K – 3541
2021
Q2 		$650K Buy
+62,807
New +$600K ﹤0.01% 2008

Other funds holding NMRD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AIP
ARS Investment Partners New York $2.29B AUM 113.95% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Marshall Wace's NMRD Position: Q3 2021 in Review

Marshall Wace sold out of Nemaura Medical, Inc. Common Stock (NMRD) in Q3 2021, closing a stake of 62,807 shares — an estimated $650K sold.

Marshall Wace first reported a position in NMRD in Q2 2021 and held it in 1 quarter. The position peaked at $650K in Q2 2021. 17 funds tracked by Wall St. Rank hold NMRD as of Q3 2021.

  • Marshall Wace reported no remaining Nemaura Medical, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
  • Marshall Wace sold 62,807 Nemaura Medical, Inc. Common Stock shares in Q3 2021, an estimated $650K.
  • Marshall Wace first reported a position in Nemaura Medical, Inc. Common Stock in Q2 2021 and held it in 1 quarter.
  • Marshall Wace's Nemaura Medical, Inc. Common Stock position peaked at $650K in Q2 2021.
  • 17 funds tracked by Wall St. Rank held Nemaura Medical, Inc. Common Stock as of Q3 2021.

Based on Marshall Wace's 13F filing for Q3 2021, filed 15 Nov 2021.